Estabrook Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$464K |
| 2 |
PepsiCo
PEP
|
+$214K |
| 3 |
Pfizer
PFE
|
+$138K |
| 4 |
Boeing
BA
|
+$101K |
| 5 |
SLB Ltd
SLB
|
+$99.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$2.71M |
| 2 |
JPMorgan Chase
JPM
|
+$2.54M |
| 3 |
Apple
AAPL
|
+$2.46M |
| 4 |
Microsoft
MSFT
|
+$1.83M |
| 5 |
Union Pacific
UNP
|
+$1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Financials | 20.44% |
| 3 | Industrials | 12.9% |
| 4 | Healthcare | 11.37% |
| 5 | Energy | 9.07% |
Similar funds
Estabrook Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Estabrook Capital Management held 349 positions worth $619M, down 4.6% from $649M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Estabrook Capital Management withdrew a net $24.3M in Q1 2025, closing 19 positions and reducing 104 holdings. Its most notable exit was CVS Health, an estimated $843K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
Against the trend, Estabrook Capital Management opened a new position in Millrose Properties Inc worth $292.
- Estabrook Capital Management's largest Q1 2025 buy was Millrose Properties Inc: 11 shares worth $292.
- Estabrook Capital Management added most to Nike in Q1 2025, an estimated $464K increase.
- Estabrook Capital Management's biggest Q1 2025 reduction was Costco, cutting an estimated $2.71M.
- Estabrook Capital Management fully exited CVS Health in Q1 2025, selling an estimated $843K.
- Estabrook Capital Management's ten largest holdings make up 44% of its $619M portfolio in Q1 2025.
- Estabrook Capital Management opened 1 new position and closed 19 in Q1 2025.
- Estabrook Capital Management's portfolio value fell 4.6% quarter-over-quarter to $619M.
Based on Estabrook Capital Management's 13F filing for Q1 2025, filed 14 May 2025.